Clinical Trial Update: The Evaluation of Lung Cancer Patient Treated With Epidermal Growth Factor Receptor Tyrosine Kinase

View source ↗

Summary

This clinical-trial update reports on the evaluation of a lung cancer patient treated with an EGFR tyrosine kinase inhibitor, with the current status not provid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Dr. Soetomo General Hospital | Conditions: Non-Small-Cell Lung Cancer | Status: UNKNOWN